Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0045785,GO:0045785,positive regulation of cell adhesion,24/191,446/18800,2.8215263842723598e-11,5.90013307965002e-08,4.08150339559001e-08,ADAM9/ADGRG1/AGR2/B2M/CCL25/CD160/CD27/CD276/CD5/CD74/DMP1/FSTL3/HAVCR2/HLA-E/IGFBP2/IL2RA/MDK/NRP1/PDCD1LG2/PLAUR/SIRPB1/TGFBR2/TNFRSF14/VCAM1,24
GO:0022407,GO:0022407,regulation of cell-cell adhesion,24/191,456/18800,4.46584849348143e-11,5.90013307965002e-08,4.08150339559001e-08,B2M/CCL25/CD160/CD27/CD276/CD5/CD74/CDH1/FSTL3/GPNMB/HAVCR2/HLA-E/IGFBP2/IL2RA/LAG3/MDK/NOTCH1/PDCD1LG2/PLAUR/SIRPB1/TGFBR2/TNFRSF14/VCAM1/VSIG4,24
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,22/191,381/18800,5.19530356294396e-11,5.90013307965002e-08,4.08150339559001e-08,APOA4/B2M/CCL25/CD160/CD27/CD276/CD5/CD74/GPNMB/HAVCR2/HLA-E/IGFBP2/IL2RA/JAM2/LAG3/MDK/PDCD1LG2/SIRPB1/TGFBR2/TNFRSF14/VCAM1/VSIG4,22
GO:0050863,GO:0050863,regulation of T cell activation,20/191,342/18800,3.3043182070002e-10,2.49433701112663e-07,1.72549412754315e-07,B2M/CD160/CD27/CD276/CD5/CD74/GPNMB/HAVCR2/HLA-E/IGFBP2/IL2RA/LAG3/MDK/PDCD1LG2/SIRPB1/TGFBR2/TNFRSF14/TNFRSF1B/VCAM1/VSIG4,20
GO:0050870,GO:0050870,positive regulation of T cell activation,16/191,223/18800,1.1272346211761e-09,5.4864119347814e-07,3.79530573956886e-07,B2M/CD160/CD27/CD276/CD5/CD74/HAVCR2/HLA-E/IGFBP2/IL2RA/MDK/PDCD1LG2/SIRPB1/TGFBR2/TNFRSF14/VCAM1,16
GO:0050867,GO:0050867,positive regulation of cell activation,21/191,436/18800,3.8708337886714905e-09,1.46532563533375e-06,1.01366045062403e-06,ACTA2/B2M/CD160/CD27/CD276/CD5/CD74/HAVCR1/HAVCR2/HLA-E/IGFBP2/IL2RA/MDK/NECTIN2/PDCD1LG2/SIRPB1/TGFBR2/TNFRSF14/TNFRSF4/TNFSF13/VCAM1,21
GO:0002697,GO:0002697,regulation of immune effector process,18/191,353/18800,2.24031016686002e-08,6.3606139487434e-06,4.40004777508735e-06,ADGRE2/B2M/CD160/CD59/CD74/GRN/HAVCR2/HLA-E/IL1R1/LAG3/NCR1/NECTIN2/SEMA7A/TNFRSF14/TNFRSF1B/TNFRSF4/TNFSF13/VSIG4,18
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,14/191,211/18800,3.4537217034504e-08,9.05140757204271e-06,6.26144363888701e-06,ACVRL1/AREG/B4GALT1/CCL11/FGFBP1/GRN/MDK/MMP12/NOTCH1/NRP1/REG3A/SCG2/SPINK1/VEGFD,14
GO:0034612,GO:0034612,response to tumor necrosis factor,15/191,249/18800,4.00281013765056e-08,9.74112438498247e-06,6.73856533699218e-06,ADAM9/CCL11/CCL15/CCL25/CD14/EDA2R/FABP4/IL18BP/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/VCAM1,15
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,14/191,230/18800,1.0132050580963e-07,2.15749352058381e-05,1.49247771386686e-05,CD276/CD74/GPNMB/HAVCR2/HLA-E/IGFBP2/IL2RA/PDCD1LG2/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,14
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,14/191,233/18800,1.18924893523115e-07,2.38339477784266e-05,1.64874821423068e-05,CD276/CD74/GPNMB/HAVCR2/HLA-E/IGFBP2/IL2RA/PDCD1LG2/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,14
GO:0043410,GO:0043410,positive regulation of MAPK cascade,20/191,491/18800,1.46608409762576e-07,2.77497140033942e-05,1.91962707285618e-05,ACTA2/ADAM9/CCL11/CCL15/CCL25/CD27/CD74/EDA2R/EFNA1/ERBB4/GCG/GDF15/GPNMB/HAVCR2/IGFBP4/NOTCH1/NRP1/SEMA7A/TNFRSF11A/TNFRSF19,20
GO:0042098,GO:0042098,T cell proliferation,13/191,204/18800,1.73037937474793e-07,3.10284343671905e-05,2.14643735183414e-05,CD276/GPNMB/HAVCR2/HLA-E/IGFBP2/IL2RA/PDCD1LG2/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,13
GO:0050900,GO:0050900,leukocyte migration,17/191,384/18800,4.19127111980249e-07,5.94985862715296e-05,4.11590177071833e-05,ADGRE2/B4GALT1/CCL11/CCL15/CCL25/CD74/IL1R1/JAM2/MDK/NBL1/PLA2G7/SCG2/TNFRSF11A/TNFRSF14/VCAM1/VEGFD/XG,17
GO:0071356,GO:0071356,cellular response to tumor necrosis factor,13/191,229/18800,6.51277021005573e-07,8.3315103716535e-05,5.76344421612846e-05,CCL11/CCL15/CCL25/EDA2R/FABP4/IL18BP/TNFRSF11A/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/VCAM1,13
GO:0050673,GO:0050673,epithelial cell proliferation,18/191,443/18800,6.60260581258129e-07,8.3315103716535e-05,5.76344421612846e-05,ACVRL1/AREG/B2M/B4GALT1/CCL11/EPHA2/FGFBP1/GRN/IGFBP4/MDK/MMP12/NOTCH1/NRP1/REG3A/SCG2/SPINK1/TACSTD2/VEGFD,18
GO:0060326,GO:0060326,cell chemotaxis,15/191,315/18800,8.32259867089424e-07,0.0001012681916847,7.00537534741813e-05,ADGRE2/CCL11/CCL15/CCL25/CD74/EPHA2/MDK/NBL1/NOTCH1/NRP1/PLA2G7/SCG2/TNFRSF11A/VCAM1/VEGFD,15
GO:0032943,GO:0032943,mononuclear cell proliferation,14/191,300/18800,2.47721038145949e-06,0.000228221387192,0.000157875484196,CD276/CD74/GPNMB/HAVCR2/HLA-E/IGFBP2/IL2RA/PDCD1LG2/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,14
GO:0046718,GO:0046718,viral entry into host cell,10/191,146/18800,2.47848292518554e-06,0.000228221387192,0.000157875484196,CD74/EPHA2/HAVCR1/ITGB6/NECTIN2/NECTIN4/NRP1/SCARB2/TNFRSF14/TNFRSF4,10
GO:0045765,GO:0045765,regulation of angiogenesis,15/191,345/18800,2.57397238092521e-06,0.0002307769447845,0.0001596433285565,ACVRL1/ADGRB3/ANGPTL4/CCL11/CD160/DCN/DLL1/EFNA1/EPHA2/GPNMB/GRN/MDK/NRP1/TGFBR2/VEGFD,15
GO:0032103,GO:0032103,positive regulation of response to external stimulus,17/191,442/18800,2.87608199248973e-06,0.0002512515730362,0.0001738069522586,CCN4/CD160/CD74/FABP4/GRN/HAVCR2/HLA-E/LAG3/MDK/MMP12/NECTIN2/NRP1/PLA2G7/SCG2/TNFRSF11A/TNFRSF1A/VEGFD,17
GO:0048754,GO:0048754,branching morphogenesis of an epithelial tube,10/191,153/18800,3.77877840072327e-06,0.0002930416190133,0.0002027158280848,AREG/CCL11/COL4A1/EPHA2/MDK/NOTCH1/NRP1/PKD1/TACSTD2/TGFBR2,10
GO:0002702,GO:0002702,positive regulation of production of molecular mediator of immune response,9/191,120/18800,3.78451166321894e-06,0.0002930416190133,0.0002027158280848,B2M/CD160/CD74/HLA-E/IL1R1/SEMA7A/TNFRSF14/TNFRSF4/TNFSF13,9
GO:0003332,GO:0003332,negative regulation of extracellular matrix constituent secretion,3/191,4/18800,4.09859034776155e-06,0.0003035629851048,0.0002099941370397,NOTCH1/TNFRSF1A/TNFRSF1B,3
GO:0044278,GO:0044278,cell wall disruption in another organism,3/191,4/18800,4.09859034776155e-06,0.0003035629851048,0.0002099941370397,REG1A/REG1B/REG3A,3
GO:0002274,GO:0002274,myeloid leukocyte activation,12/191,232/18800,4.65115554588072e-06,0.0003371592966982,0.0002332348772055,ADAM9/ADGRE2/CD74/GRN/HAVCR1/HAVCR2/ITGB6/NECTIN2/PLA2G10/PTGDS/TGFBR2/VSIG4,12
GO:0031589,GO:0031589,cell-substrate adhesion,15/191,364/18800,4.9424052191697e-06,0.0003410105871697,0.0002358990637458,ACVRL1/ADAM9/AGR2/CCL25/DMP1/EFNA1/ITGB6/MDK/MMP12/NOTCH1/NRP1/PKD1/SPOCK1/TACSTD2/VCAM1,15
GO:0007411,GO:0007411,axon guidance,12/191,234/18800,5.07849211252763e-06,0.0003410105871697,0.0002358990637458,BOC/EFNA1/EFNA4/EPHA2/EPHB4/NFASC/NOTCH1/NRCAM/NRP1/PLA2G10/PLXNB2/SEMA7A,12
GO:0090130,GO:0090130,tissue migration,15/191,366/18800,5.28024079276701e-06,0.0003410105871697,0.0002358990637458,ACTA2/ACVRL1/ADAM9/CLEC14A/DCN/EFNA1/EPHA2/EPHB4/FGFBP1/GRN/NOTCH1/NRP1/SCG2/TACSTD2/TGFBR2,15
GO:0050868,GO:0050868,negative regulation of T cell activation,9/191,125/18800,5.29819434579163e-06,0.0003410105871697,0.0002358990637458,CD74/GPNMB/HAVCR2/IL2RA/LAG3/MDK/PDCD1LG2/TNFRSF14/VSIG4,9
GO:0097485,GO:0097485,neuron projection guidance,12/191,235/18800,5.3048315585544e-06,0.0003410105871697,0.0002358990637458,BOC/EFNA1/EFNA4/EPHA2/EPHB4/NFASC/NOTCH1/NRCAM/NRP1/PLA2G10/PLXNB2/SEMA7A,12
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,13/191,279/18800,5.81363730501118e-06,0.0003601284054213,0.0002491240942759,CD164/CDH1/CDH17/DSC2/DSG2/NECTIN2/NECTIN4/PKD1/PLXNB2/REG3A/SCARF2/TGFBR2/VCAM1,13
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,6/191,46/18800,6.79122370968458e-06,0.0004106953341627,0.0002841045071881,CD160/HAVCR2/HLA-E/LAG3/NCR1/NECTIN2,6
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,4/191,13/18800,6.87104022520639e-06,0.0004106953341627,0.0002841045071881,CST3/NOTCH1/TNFRSF1A/TNFRSF1B,4
GO:0002367,GO:0002367,cytokine production involved in immune response,8/191,100/18800,8.21390281511393e-06,0.0004487144474194,0.0003104047851241,B2M/CD160/CD74/HLA-E/IL1R1/SEMA7A/TNFRSF14/TNFRSF1B,8
GO:0031341,GO:0031341,regulation of cell killing,8/191,100/18800,8.21390281511393e-06,0.0004487144474194,0.0003104047851241,B2M/CD160/CD59/HAVCR2/HLA-E/LAG3/NCR1/NECTIN2,8
GO:0031349,GO:0031349,positive regulation of defense response,13/191,289/18800,8.49693063425522e-06,0.0004487144474194,0.0003104047851241,CCN4/CD160/FABP4/GRN/HAVCR2/HLA-E/LAG3/MDK/MMP12/NECTIN2/PLA2G7/TNFRSF11A/TNFRSF1A,13
GO:0001667,GO:0001667,ameboidal-type cell migration,17/191,480/18800,8.56073938428631e-06,0.0004487144474194,0.0003104047851241,ACTA2/ACVRL1/ADAM9/CLEC14A/DCN/EFNA1/EPHA2/EPHB4/ERBB4/FGFBP1/GRN/NOTCH1/NRP1/SCG2/SEMA7A/TACSTD2/TGFBR2,17
GO:0070371,GO:0070371,ERK1 and ERK2 cascade,14/191,335/18800,8.80454198354123e-06,0.0004545011293625,0.0003144078070358,ACTA2/CCL11/CCL15/CCL25/CD74/EPHA2/ERBB4/GCG/GPNMB/HAVCR2/NOTCH1/NRP1/SEMA7A/TNFRSF11A,14
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,3/191,5/18800,1.01696504992781e-05,0.0005049446489666,0.0003493028498714,NOTCH1/TNFRSF1A/TNFRSF1B,3
GO:0022600,GO:0022600,digestive system process,8/191,104/18800,1.098328805152e-05,0.0005345368510886,0.0003697736887175,APOA4/FABP1/MDK/MUC13/SPINK1/TFF1/TFF2/TFF3,8
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,7/191,85/18800,2.53104187262192e-05,0.0011055461102593,0.0007647776994332,B2M/CD160/HAVCR2/HLA-E/LAG3/NCR1/NECTIN2,7
GO:0002695,GO:0002695,negative regulation of leukocyte activation,10/191,193/18800,2.89445877209443e-05,0.0012174593872254,0.0008421953464222,CD74/GPNMB/GRN/HAVCR2/IL2RA/LAG3/MDK/PDCD1LG2/TNFRSF14/VSIG4,10
GO:0032102,GO:0032102,negative regulation of response to external stimulus,15/191,429/18800,3.42020002900169e-05,0.0013708966469186,0.0009483378160909,GRN/HAVCR2/HLA-E/IL2RA/MDK/MMP12/NBL1/NOTCH1/NRP1/PLA2G10/RTN4R/SEMA7A/TNFRSF1A/TNFRSF1B/VSIG4,15
GO:2000391,GO:2000391,positive regulation of neutrophil extravasation,3/191,7/18800,3.50624000244881e-05,0.0013755741421909,0.0009515735418922,IL1R1/MDK/XG,3
GO:0001763,GO:0001763,morphogenesis of a branching structure,10/191,199/18800,3.75762570735019e-05,0.0014384528971845,0.0009950708407755,AREG/CCL11/COL4A1/EPHA2/MDK/NOTCH1/NRP1/PKD1/TACSTD2/TGFBR2,10
GO:0051960,GO:0051960,regulation of nervous system development,15/191,440/18800,4.56513352262454e-05,0.0017091659243496,0.0011823405387109,ADGRB3/AGRN/B2M/CCL11/DLL1/JAM2/MDK/NEFL/NOTCH1/NRP1/PLXNB2/RTN4R/SEMA7A/SLITRK6/TNFRSF1B,15
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,11/191,251/18800,5.38371696170341e-05,0.001993730835709,0.001379192480235,AMBP/CD27/COL6A3/CST3/FABP1/ITIH3/PLAUR/SPINK1/SPINK4/SPOCK1/WFDC2,11
GO:0030277,GO:0030277,maintenance of gastrointestinal epithelium,4/191,22/18800,6.54359955485942e-05,0.0023650909598271,0.0016360862802753,MUC13/TFF1/TFF2/TFF3,4
GO:0002443,GO:0002443,leukocyte mediated immunity,15/191,457/18800,6.99942889018775e-05,0.0024840681488405,0.0017183904917906,ADGRE2/B2M/C7/CD160/CD27/CD74/HAVCR2/HLA-E/IL1R1/LAG3/NCR1/NECTIN2/PTGDS/TNFRSF1B/TNFSF13,15
GO:0036303,GO:0036303,lymph vessel morphogenesis,4/191,23/18800,7.85848894071773e-05,0.0026684647808722,0.0018459495603086,ACVRL1/CLEC14A/EPHA2/PKD1,4
GO:0007586,GO:0007586,digestion,8/191,137/18800,8.01777720469188e-05,0.0026746116095056,0.0018502017189634,APOA4/FABP1/MDK/MUC13/SPINK1/TFF1/TFF2/TFF3,8
GO:1904238,GO:1904238,pericyte cell differentiation,3/191,9/18800,8.28946582305168e-05,0.0026897342913463,0.0018606630554198,ACTA2/EPHA2/NOTCH1,3
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,6/191,72/18800,9.10274913356266e-05,0.0029243453920579,0.0020229587174448,CD160/HAVCR2/HLA-E/LAG3/NCR1/NECTIN2,6
GO:0050777,GO:0050777,negative regulation of immune response,9/191,179/18800,9.18417836660411e-05,0.0029243453920579,0.0020229587174448,AMBP/CD160/CD59/GRN/HAVCR2/HLA-E/MMP12/TNFRSF14/VSIG4,9
GO:0050808,GO:0050808,synapse organization,14/191,419/18800,0.0001016366608185,0.0030158415159764,0.0020862525000451,ADGRB3/AGRN/BCAN/CDH1/CHCHD10/COL4A1/EFNA1/ERBB4/NEFL/NFASC/NRCAM/NRP1/PLXNB2/SLITRK6,14
GO:0044269,GO:0044269,glycerol ether catabolic process,2/191,2/18800,0.0001026820122844,0.0030158415159764,0.0020862525000451,PLA2G10/PLA2G7,2
GO:0062234,GO:0062234,platelet activating factor catabolic process,2/191,2/18800,0.0001026820122844,0.0030158415159764,0.0020862525000451,PLA2G10/PLA2G7,2
GO:0097102,GO:0097102,endothelial tip cell fate specification,2/191,2/18800,0.0001026820122844,0.0030158415159764,0.0020862525000451,DLL1/NRP1,2
GO:1901502,GO:1901502,ether catabolic process,2/191,2/18800,0.0001026820122844,0.0030158415159764,0.0020862525000451,PLA2G10/PLA2G7,2
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,6/191,74/18800,0.0001061337147927,0.0030868458502326,0.0021353707872865,DCN/DLL1/NOTCH1/NRP1/VCAM1/VEGFD,6
GO:0060249,GO:0060249,anatomical structure homeostasis,12/191,319/18800,0.0001069883309736,0.0030868458502326,0.0021353707872865,B2M/BGLAP/ITGB6/JAM2/MUC13/NOTCH1/PIGR/SCGN/TFF1/TFF2/TFF3/TNFRSF11A,12
GO:0051346,GO:0051346,negative regulation of hydrolase activity,13/191,371/18800,0.0001127107141125,0.0031219951461919,0.0021596858271125,AMBP/ANGPTL4/CD27/COL6A3/CST3/FABP1/ITIH3/LEPR/PLAUR/SPINK1/SPINK4/SPOCK1/WFDC2,13
GO:0002040,GO:0002040,sprouting angiogenesis,9/191,186/18800,0.0001230276845166,0.0032746509464696,0.0022652877107952,ACVRL1/CLEC14A/DLL1/EPHA2/EPHB4/FGFBP1/NOTCH1/NRP1/VEGFD,9
GO:0042060,GO:0042060,wound healing,14/191,429/18800,0.0001301251789107,0.0034367169344888,0.0023773992295492,ACTA2/ACVRL1/ANXA5/B4GALT1/CCN4/CD59/DCBLD2/ITGB6/MCAM/MMP12/PLAUR/REG3A/TGFBR2/TNFRSF12A,14
GO:1903131,GO:1903131,mononuclear cell differentiation,14/191,433/18800,0.0001433257417412,0.0036441104635254,0.0025208667380882,B2M/CD27/CD74/CD79B/CDH17/DLL1/IL2RA/ITGB6/LAG3/LEPR/MDK/ST3GAL1/TGFBR2/VCAM1,14
GO:0010632,GO:0010632,regulation of epithelial cell migration,11/191,290/18800,0.0001930988723832,0.0047117674049198,0.0032594340505199,ACVRL1/ADAM9/DCN/EFNA1/EPHA2/FGFBP1/GRN/NOTCH1/NRP1/TACSTD2/TGFBR2,11
GO:0009612,GO:0009612,response to mechanical stimulus,9/191,201/18800,0.0002203692453421,0.0052138751311156,0.0036067744175514,BGLAP/IGFBP2/MDK/PKD1/SLITRK6/TGFBR2/TNFRSF10A/TNFRSF10B/TNFRSF1A,9
GO:0034103,GO:0034103,regulation of tissue remodeling,6/191,86/18800,0.0002435801988445,0.0056454267854654,0.0039053065894233,BGLAP/CST3/GPNMB/LEPR/MDK/TNFRSF11A,6
GO:0002507,GO:0002507,tolerance induction,4/191,31/18800,0.0002620601831895,0.0059847250505378,0.0041400211293017,HAVCR2/HLA-E/IL2RA/TGFBR2,4
GO:0022612,GO:0022612,gland morphogenesis,7/191,123/18800,0.0002634895091225,0.0059847250505378,0.0041400211293017,AREG/CCL11/EPHA2/MDK/NOTCH1/NRP1/TGFBR2,7
GO:0045605,GO:0045605,negative regulation of epidermal cell differentiation,3/191,13/18800,0.0002738917834825,0.006099015074019,0.0042190829254719,DLL1/NOTCH1/REG3A,3
GO:0045683,GO:0045683,negative regulation of epidermis development,3/191,13/18800,0.0002738917834825,0.006099015074019,0.0042190829254719,DLL1/NOTCH1/REG3A,3
GO:0002477,GO:0002477,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,2/191,3/18800,0.0003059812533316,0.0062799887355475,0.0043442741040553,B2M/HLA-E,2
GO:0014028,GO:0014028,notochord formation,2/191,3/18800,0.0003059812533316,0.0062799887355475,0.0043442741040553,EFNA1/EPHA2,2
GO:0034441,GO:0034441,plasma lipoprotein particle oxidation,2/191,3/18800,0.0003059812533316,0.0062799887355475,0.0043442741040553,APOA4/PLA2G7,2
GO:0090716,GO:0090716,adaptive immune memory response,2/191,3/18800,0.0003059812533316,0.0062799887355475,0.0043442741040553,CD160/TNFRSF14,2
GO:0070229,GO:0070229,negative regulation of lymphocyte apoptotic process,4/191,33/18800,0.0003354480628847,0.0066186919521646,0.0045785770104573,CD27/CD74/EFNA1/ST3GAL1,4
GO:0048639,GO:0048639,positive regulation of developmental growth,8/191,169/18800,0.0003398296230046,0.0066223443875998,0.0045811036361163,AGR2/AGRN/DLL1/ERBB4/NOTCH1/NRP1/SEMA7A/TGFBR2,8
GO:0070278,GO:0070278,extracellular matrix constituent secretion,3/191,14/18800,0.0003459868802444,0.0066223443875998,0.0045811036361163,NOTCH1/TNFRSF1A/TNFRSF1B,3
GO:0031214,GO:0031214,biomineral tissue development,8/191,170/18800,0.0003535625926708,0.0067295405208364,0.0046552581299036,ATRAID/BGLAP/CLEC3B/DMP1/ITGB6/KLK4/NELL1/NOTCH1,8
GO:0001503,GO:0001503,ossification,13/191,420/18800,0.0003765388950799,0.007127044530764,0.004930237345521,AREG/ATRAID/BGLAP/CCN4/CLEC3B/DMP1/EPHA2/FSTL3/MDK/NELL1/NOTCH1/SEMA7A/TNFRSF11A,13
GO:0110148,GO:0110148,biomineralization,8/191,172/18800,0.0003823867391354,0.007197743758202,0.0049791445706562,ATRAID/BGLAP/CLEC3B/DMP1/ITGB6/KLK4/NELL1/NOTCH1,8
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,7/191,131/18800,0.0003868105464332,0.0072410084159225,0.0050090735307341,B2M/CD160/HAVCR2/HLA-E/LAG3/NCR1/NECTIN2,7
GO:0019058,GO:0019058,viral life cycle,11/191,317/18800,0.0004126990535272,0.0076427209777395,0.0052869640737055,CD74/EPHA2/HAVCR1/ITGB6/NECTIN2/NECTIN4/NOTCH1/NRP1/SCARB2/TNFRSF14/TNFRSF4,11
GO:0048771,GO:0048771,tissue remodeling,8/191,174/18800,0.0004130959925076,0.0076427209777395,0.0052869640737055,ACVRL1/BGLAP/CST3/EPHA2/GPNMB/LEPR/MDK/TNFRSF11A,8
GO:0043030,GO:0043030,regulation of macrophage activation,5/191,62/18800,0.0004157389128855,0.0076427209777395,0.0052869640737055,CD74/GRN/HAVCR2/PLA2G10/VSIG4,5
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,12/191,370/18800,0.0004172427654416,0.0076427209777395,0.0052869640737055,B2M/C7/CD27/CD74/HAVCR2/HLA-E/IL18BP/IL1R1/NECTIN2/NOTCH1/TNFRSF1B/TNFSF13,12
GO:0031348,GO:0031348,negative regulation of defense response,10/191,268/18800,0.0004289714200848,0.0077367016194621,0.0053519765578532,GRN/HAVCR2/HLA-E/IL2RA/MDK/MMP12/PLA2G10/TNFRSF1A/TNFRSF1B/VSIG4,10
GO:0050918,GO:0050918,positive chemotaxis,5/191,64/18800,0.0004818962105464,0.0085959182687526,0.0059463522480766,CCL15/GPNMB/NRP1/SCG2/VEGFD,5
GO:0050920,GO:0050920,regulation of chemotaxis,9/191,225/18800,0.0005038965453472,0.0089415392187402,0.006185440597766,CD74/MDK/NBL1/NOTCH1/NRP1/PLA2G7/SCG2/SEMA7A/VEGFD,9
GO:0003170,GO:0003170,heart valve development,5/191,65/18800,0.0005178010922813,0.0090935480484666,0.0062905949301026,EFNA1/NOTCH1/TGFBR2/TNFRSF1A/TNFRSF1B,5
GO:0060046,GO:0060046,regulation of acrosome reaction,3/191,16/18800,0.000524374382014,0.0091178260360912,0.0063073895833062,B4GALT1/PLA2G10/SPINK1,3
GO:0045632,GO:0045632,negative regulation of mechanoreceptor differentiation,2/191,4/18800,0.0006078639163155,0.0101192457361536,0.0070001363147847,DLL1/NOTCH1,2
GO:1905653,GO:1905653,positive regulation of artery morphogenesis,2/191,4/18800,0.0006078639163155,0.0101192457361536,0.0070001363147847,MDK/NOTCH1,2
GO:0060284,GO:0060284,regulation of cell development,14/191,500/18800,0.000612144393429,0.0101241550893826,0.0070035324317203,B2M/CCL11/DLL1/GRN/MDK/NEFL/NOTCH1/NRP1/PLXNB2/RTN4R/SEMA7A/TACSTD2/TNFRSF1A/TNFRSF1B,14
GO:0001906,GO:0001906,cell killing,8/191,185/18800,0.0006199096034117,0.0102030532310325,0.0070581113757378,B2M/CD160/CD59/HAVCR2/HLA-E/LAG3/NCR1/NECTIN2,8
GO:0031099,GO:0031099,regeneration,8/191,188/18800,0.0006888541216853,0.0111647016684465,0.0077233457542989,APOA4/ERBB4/GRN/MDK/NEFL/NOTCH1/RTN4R/TGFBR2,8
GO:0002366,GO:0002366,leukocyte activation involved in immune response,10/191,285/18800,0.0006914446880076,0.0111647016684465,0.0077233457542989,ADGRE2/CD74/CDH17/DLL1/GRN/HAVCR2/MDK/PTGDS/ST3GAL1/TNFSF13,10
GO:0050731,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,8/191,190/18800,0.0007381578683256,0.0118070603633117,0.0081677067812259,AREG/CD74/EFNA1/ERBB4/GFRA1/NRP1/TNFRSF14/TNFRSF1A,8
GO:0052547,GO:0052547,regulation of peptidase activity,13/191,456/18800,0.0008110832807908,0.012675966686489,0.0087687854451512,AMBP/CD27/COL6A3/CST3/EFNA1/FABP1/GRN/ITIH3/PLAUR/SPINK1/SPINK4/SPOCK1/WFDC2,13
GO:0002347,GO:0002347,response to tumor cell,4/191,42/18800,0.0008545023159594,0.0132331335930635,0.0091542138059009,CD160/HAVCR2/NECTIN2/NOTCH1,4
GO:0061298,GO:0061298,retina vasculature development in camera-type eye,3/191,19/18800,0.0008872206694334,0.0134944679498202,0.0093349956713414,ACVRL1/COL4A1/NRP1,3
GO:0070227,GO:0070227,lymphocyte apoptotic process,5/191,75/18800,0.0009970836967553,0.0149067620520763,0.0103119707829388,CD27/CD74/EFNA1/IL2RA/ST3GAL1,5
GO:0007386,GO:0007386,compartment pattern specification,2/191,5/18800,0.001006326760193,0.0149067620520763,0.0103119707829388,DLL1/NOTCH1,2
GO:0060309,GO:0060309,elastin catabolic process,2/191,5/18800,0.001006326760193,0.0149067620520763,0.0103119707829388,CST3/MMP12,2
GO:0060435,GO:0060435,bronchiole development,2/191,5/18800,0.001006326760193,0.0149067620520763,0.0103119707829388,ITGB6/MMP12,2
GO:0072144,GO:0072144,glomerular mesangial cell development,2/191,5/18800,0.001006326760193,0.0149067620520763,0.0103119707829388,ACTA2/NOTCH1,2
GO:0002237,GO:0002237,response to molecule of bacterial origin,11/191,354/18800,0.0010248757010664,0.0150200574164243,0.0103903445090986,ADAM9/B2M/CD14/HAVCR2/IL18BP/NOTCH1/PDCD1LG2/REN/TNFRSF11A/TNFRSF1B/VCAM1,11
GO:0002837,GO:0002837,regulation of immune response to tumor cell,3/191,20/18800,0.0010360180489755,0.0150200574164243,0.0103903445090986,CD160/HAVCR2/NECTIN2,3
GO:0032729,GO:0032729,positive regulation of interferon-gamma production,5/191,77/18800,0.0011229443560012,0.0160750900037657,0.0111201787398796,CD14/CD160/CD276/HAVCR2/IL1R1,5
GO:0002064,GO:0002064,epithelial cell development,8/191,203/18800,0.0011322679166736,0.0160776797007979,0.0111219702006972,ACTA2/B4GALT1/COL18A1/DLL1/EPHA2/NOTCH1/POF1B/TNFRSF1A,8
GO:0031960,GO:0031960,response to corticosteroid,7/191,157/18800,0.0011325632897538,0.0160776797007979,0.0111219702006972,ADAM9/AREG/BGLAP/IGFBP2/MDK/NEFL/NOTCH1,7
GO:0033674,GO:0033674,positive regulation of kinase activity,13/191,476/18800,0.0011974206877223,0.0168203927302044,0.0116357528070467,ADAM9/AREG/CD74/EFNA1/EPHA2/EPHB4/ERBB4/GCG/PKD1/TGFBR2/TNFRSF10A/TNFRSF10B/TNFRSF11A,13
GO:0050767,GO:0050767,regulation of neurogenesis,11/191,361/18800,0.0011995498007355,0.0168203927302044,0.0116357528070467,B2M/CCL11/DLL1/MDK/NEFL/NOTCH1/NRP1/PLXNB2/RTN4R/SEMA7A/TNFRSF1B,11
GO:0032609,GO:0032609,interferon-gamma production,6/191,117/18800,0.0012506430601721,0.0172507728988113,0.0119334745865134,CD14/CD160/CD276/HAVCR2/IL1R1/PDCD1LG2,6
GO:0042742,GO:0042742,defense response to bacterium,11/191,364/18800,0.0012815720665914,0.0176061130277297,0.0121792863204507,CD160/COLEC12/EPHA2/GRN/HAVCR2/HLA-E/LPO/RNASE6/TNFRSF14/TNFRSF1A/WFDC2,11
GO:0002440,GO:0002440,production of molecular mediator of immune response,10/191,312/18800,0.0013710634410628,0.0184941977258953,0.0127936319059149,B2M/CD160/CD74/HLA-E/IL1R1/SEMA7A/TNFRSF14/TNFRSF1B/TNFRSF4/TNFSF13,10
GO:0072001,GO:0072001,renal system development,10/191,312/18800,0.0013710634410628,0.0184941977258953,0.0127936319059149,ACTA2/COL4A1/DLL1/ERBB4/GFRA1/NOTCH1/NRP1/PKD1/REN/TACSTD2,10
GO:0002834,GO:0002834,regulation of response to tumor cell,3/191,22/18800,0.0013787866810617,0.0184941977258953,0.0127936319059149,CD160/HAVCR2/NECTIN2,3
GO:0010226,GO:0010226,response to lithium ion,3/191,22/18800,0.0013787866810617,0.0184941977258953,0.0127936319059149,CDH1/FABP4/IGFBP2,3
GO:0014807,GO:0014807,regulation of somitogenesis,2/191,6/18800,0.0014993967038738,0.0192046788349551,0.013285117609709,DLL1/NOTCH1,2
GO:0045162,GO:0045162,clustering of voltage-gated sodium channels,2/191,6/18800,0.0014993967038738,0.0192046788349551,0.013285117609709,AGRN/NRCAM,2
GO:0072143,GO:0072143,mesangial cell development,2/191,6/18800,0.0014993967038738,0.0192046788349551,0.013285117609709,ACTA2/NOTCH1,2
GO:0086073,GO:0086073,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,2/191,6/18800,0.0014993967038738,0.0192046788349551,0.013285117609709,DSC2/DSG2,2
GO:1905671,GO:1905671,regulation of lysosome organization,2/191,6/18800,0.0014993967038738,0.0192046788349551,0.013285117609709,GRN/SCARB2,2
GO:0006959,GO:0006959,humoral immune response,10/191,317/18800,0.0015426571917551,0.0196113173593649,0.0135664157593864,C7/CD59/HLA-E/NOTCH1/REG1A/REG1B/REG3A/RNASE6/VSIG4/WFDC2,10
GO:0019730,GO:0019730,antimicrobial humoral response,6/191,122/18800,0.0015504052960969,0.0196316335777523,0.0135804698007469,HLA-E/REG1A/REG1B/REG3A/RNASE6/WFDC2,6
GO:1903034,GO:1903034,regulation of response to wounding,7/191,166/18800,0.0015620608191841,0.0196381594500389,0.0135849841683954,ACTA2/CCN4/GRN/MDK/REG3A/RTN4R/TNFRSF12A,7
GO:0032092,GO:0032092,positive regulation of protein binding,5/191,83/18800,0.0015714160121989,0.019641004937738,0.0135869525761499,B2M/GCG/NRP1/PKD1/SPON1,5
GO:0006692,GO:0006692,prostanoid metabolic process,4/191,50/18800,0.0016506237331004,0.0200217026262176,0.0138503057729755,CD74/PLA2G10/PTGDS/TNFRSF1A,4
GO:0006693,GO:0006693,prostaglandin metabolic process,4/191,50/18800,0.0016506237331004,0.0200217026262176,0.0138503057729755,CD74/PLA2G10/PTGDS/TNFRSF1A,4
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,4/191,50/18800,0.0016506237331004,0.0200217026262176,0.0138503057729755,DCN/DLL1/NRP1/VEGFD,4
GO:0030900,GO:0030900,forebrain development,11/191,376/18800,0.0016572116643948,0.0200217026262176,0.0138503057729755,ADGRG1/B2M/BCAN/CDH1/ERBB4/MDK/NEFL/NOTCH1/NRP1/RTN4R/SEMA7A,11
GO:0032330,GO:0032330,regulation of chondrocyte differentiation,4/191,51/18800,0.0017770466122022,0.0213936318295869,0.0147993578751008,ACVRL1/CCN4/MDK/WNT9A,4
GO:0031103,GO:0031103,axon regeneration,4/191,52/18800,0.0019100311886866,0.0227534134959979,0.0157400067407781,APOA4/GRN/NEFL/RTN4R,4
GO:0048013,GO:0048013,ephrin receptor signaling pathway,4/191,52/18800,0.0019100311886866,0.0227534134959979,0.0157400067407781,EFNA1/EFNA4/EPHA2/EPHB4,4
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,8/191,221/18800,0.0019376908312515,0.0230024831431147,0.0159123043138534,CD27/NRP1/SCG2/TNFRSF10A/TNFRSF10B/TNFRSF12A/TNFRSF1A/TNFRSF1B,8
GO:0097186,GO:0097186,amelogenesis,3/191,25/18800,0.0020136631101073,0.0236570697108123,0.016365124150745,DMP1/ITGB6/KLK4,3
GO:0002709,GO:0002709,regulation of T cell mediated immunity,5/191,88/18800,0.0020357180012113,0.023752367226463,0.0164310476017026,B2M/HLA-E/IL1R1/NECTIN2/TNFRSF1B,5
GO:0045590,GO:0045590,negative regulation of regulatory T cell differentiation,2/191,7/18800,0.0020851304254135,0.0238390582529662,0.016491017387852,LAG3/MDK,2
GO:0086042,GO:0086042,cardiac muscle cell-cardiac muscle cell adhesion,2/191,7/18800,0.0020851304254135,0.0238390582529662,0.016491017387852,DSC2/DSG2,2
GO:0019883,GO:0019883,antigen processing and presentation of endogenous antigen,3/191,26/18800,0.0022594168047255,0.0254053896161714,0.0175745500287667,B2M/CD74/HLA-E,3
GO:0060384,GO:0060384,innervation,3/191,26/18800,0.0022594168047255,0.0254053896161714,0.0175745500287667,NRP1/SLITRK6/VCAM1,3
GO:0060561,GO:0060561,apoptotic process involved in morphogenesis,3/191,26/18800,0.0022594168047255,0.0254053896161714,0.0175745500287667,NOTCH1/TNFRSF1A/TNFRSF1B,3
GO:0003158,GO:0003158,endothelium development,6/191,133/18800,0.002399991470199,0.0268090850457973,0.0185455768827461,ACVRL1/COL18A1/DLL1/NOTCH1/NRP1/TNFRSF1A,6
GO:0002833,GO:0002833,positive regulation of response to biotic stimulus,7/191,180/18800,0.0024710728105657,0.027366379392335,0.0189310934019551,CD160/GRN/HAVCR2/HLA-E/LAG3/MMP12/NECTIN2,7
GO:0007416,GO:0007416,synapse assembly,7/191,180/18800,0.0024710728105657,0.027366379392335,0.0189310934019551,ADGRB3/AGRN/CDH1/ERBB4/NRCAM/PLXNB2/SLITRK6,7
GO:0040013,GO:0040013,negative regulation of locomotion,11/191,396/18800,0.0024805208482909,0.027366379392335,0.0189310934019551,ACVRL1/ADGRG1/CCL25/CD74/CDH1/DCN/NBL1/NOTCH1/NRP1/SEMA7A/TACSTD2,11
GO:0002418,GO:0002418,immune response to tumor cell,3/191,27/18800,0.0025229839551564,0.0275506613308268,0.0190585731295386,CD160/HAVCR2/NECTIN2,3
GO:0098773,GO:0098773,skin epidermis development,5/191,93/18800,0.0025930236274439,0.0280458142815916,0.0194011024288952,DKK4/DLL1/NOTCH1/PLA2G10/TNFRSF19,5
GO:0046456,GO:0046456,icosanoid biosynthetic process,4/191,57/18800,0.0026793823217973,0.0281701161159969,0.0194870900417768,CD74/GGT5/PLA2G10/PTGDS,4
GO:0045582,GO:0045582,positive regulation of T cell differentiation,5/191,94/18800,0.002716535575219,0.0281701161159969,0.0194870900417768,CD27/CD74/IL2RA/MDK/TGFBR2,5
GO:0060560,GO:0060560,developmental growth involved in morphogenesis,8/191,234/18800,0.0027593850640357,0.0281701161159969,0.0194870900417768,AREG/CCL11/NOTCH1/NRCAM/NRP1/RTN4R/SEMA7A/TGFBR2,8
GO:0045136,GO:0045136,development of secondary sexual characteristics,2/191,8/18800,0.0027616139661705,0.0281701161159969,0.0194870900417768,AREG/B4GALT1,2
GO:0062043,GO:0062043,positive regulation of cardiac epithelial to mesenchymal transition,2/191,8/18800,0.0027616139661705,0.0281701161159969,0.0194870900417768,NOTCH1/TGFBR2,2
GO:1905247,GO:1905247,positive regulation of aspartic-type peptidase activity,2/191,8/18800,0.0027616139661705,0.0281701161159969,0.0194870900417768,EFNA1/GRN,2
GO:0032703,GO:0032703,negative regulation of interleukin-2 production,3/191,28/18800,0.0028047858584227,0.0285250908049143,0.0197326489772459,HAVCR2/LAG3/VSIG4,3
GO:0097305,GO:0097305,response to alcohol,8/191,235/18800,0.0028323735455102,0.0286347082182594,0.0198084784269794,BGLAP/CD14/CD27/CDH1/NEFL/SPINK1/TGFBR2/VCAM1,8
GO:0042063,GO:0042063,gliogenesis,9/191,291/18800,0.0029968133769017,0.0300298328679532,0.0207735763185229,ADGRG1/AREG/DLL1/FGF5/GRN/LEPR/MDK/NOTCH1/TNFRSF1B,9
GO:0000768,GO:0000768,syncytium formation by plasma membrane fusion,4/191,59/18800,0.003039008711152,0.0300985542991138,0.0208211153741418,ADAM9/ADGRB3/GDF15/JAM2,4
GO:0140253,GO:0140253,cell-cell fusion,4/191,59/18800,0.003039008711152,0.0300985542991138,0.0208211153741418,ADAM9/ADGRB3/GDF15/JAM2,4
GO:0031345,GO:0031345,negative regulation of cell projection organization,7/191,188/18800,0.0031477127605412,0.0304666402703522,0.0210757442310162,B2M/EFNA1/NRP1/RTN4R/SEMA7A/SPOCK1/TACSTD2,7
GO:0001649,GO:0001649,osteoblast differentiation,8/191,241/18800,0.0033025244390588,0.0317844654346713,0.0219873690724141,AREG/ATRAID/BGLAP/CCN4/EPHA2/NELL1/NOTCH1/SEMA7A,8
GO:0021700,GO:0021700,developmental maturation,9/191,296/18800,0.0033535449035244,0.0320941783323255,0.0222016175014527,ACVRL1/ADGRB3/AGRN/BCAN/NEFL/NRCAM/PLA2G10/REN/SPINK1,9
GO:0034368,GO:0034368,protein-lipid complex remodeling,3/191,30/18800,0.0034246880306619,0.0322154442142872,0.0222855049498058,APOA4/PLA2G10/PLA2G7,3
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,4/191,61/18800,0.0034302706912789,0.0322154442142872,0.0222855049498058,DSC2/DSG2/NRCAM/VCAM1,4
GO:0008544,GO:0008544,epidermis development,10/191,355/18800,0.0034969994008018,0.0322154442142872,0.0222855049498058,ADAM9/DKK4/DLL1/EDA2R/EPHA2/NOTCH1/PLA2G10/REG3A/SLITRK6/TNFRSF19,10
GO:0051541,GO:0051541,elastin metabolic process,2/191,9/18800,0.0035269623398676,0.0322154442142872,0.0222855049498058,CST3/MMP12,2
GO:0060982,GO:0060982,coronary artery morphogenesis,2/191,9/18800,0.0035269623398676,0.0322154442142872,0.0222855049498058,NOTCH1/NRP1,2
GO:0034329,GO:0034329,cell junction assembly,11/191,420/18800,0.0038765240034886,0.0347560981049624,0.0240430394565402,ACVRL1/ADGRB3/AGRN/CDH1/EPHA2/ERBB4/NRCAM/NRP1/PLXNB2/POF1B/SLITRK6,11
GO:0110149,GO:0110149,regulation of biomineralization,5/191,103/18800,0.0040272146949893,0.0359181164026929,0.0248468826180246,ATRAID/BGLAP/DMP1/NELL1/NOTCH1,5
GO:0001516,GO:0001516,prostaglandin biosynthetic process,3/191,32/18800,0.0041221349650375,0.0364782177295661,0.0252343409069558,CD74/PLA2G10/PTGDS,3
GO:0046457,GO:0046457,prostanoid biosynthetic process,3/191,32/18800,0.0041221349650375,0.0364782177295661,0.0252343409069558,CD74/PLA2G10/PTGDS,3
GO:0010675,GO:0010675,regulation of cellular carbohydrate metabolic process,6/191,150/18800,0.0043460517172965,0.0378688840917007,0.0261963547128414,FAM3C/GCG/IGFBP4/LEPR/SCARB2/TFF3,6
GO:1901890,GO:1901890,positive regulation of cell junction assembly,5/191,105/18800,0.0043707132949027,0.0378688840917007,0.0261963547128414,ADGRB3/AGRN/EPHA2/NRP1/SLITRK6,5
GO:0021562,GO:0021562,vestibulocochlear nerve development,2/191,10/18800,0.0043793191465013,0.0378688840917007,0.0261963547128414,NRP1/SLITRK6,2
GO:0007178,GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,10/191,368/18800,0.0044982515563009,0.0384667276029543,0.026609921710106,ACVRL1/ADAM9/AFP/FSTL3/GDF15/ITGB6/LTBP2/NBL1/NOTCH1/TGFBR2,10
GO:1901652,GO:1901652,response to peptide,12/191,491/18800,0.0045120609462734,0.0384667276029543,0.026609921710106,AREG/BGLAP/GDF15/MMP12/NEFL/NOTCH1/REG1A/REG1B/REG3A/SPINK1/TFF1/VCAM1,12
GO:0007631,GO:0007631,feeding behavior,5/191,106/18800,0.0045500708024627,0.0384667276029543,0.026609921710106,GCG/GDF15/LEPR/PYY/REN,5
GO:0045927,GO:0045927,positive regulation of growth,8/191,256/18800,0.0047443748738172,0.0397151970395467,0.0274735687119537,AGR2/AGRN/DLL1/ERBB4/NOTCH1/NRP1/SEMA7A/TGFBR2,8
GO:1903706,GO:1903706,regulation of hemopoiesis,10/191,371/18800,0.0047586200612756,0.0397368101685441,0.0274885199102066,B2M/BGLAP/CD27/CD74/DLL1/FSTL3/IL2RA/LAG3/MDK/TGFBR2,10
GO:0043627,GO:0043627,response to estrogen,4/191,68/18800,0.0050672020775696,0.0418013498263433,0.0289166954292811,BGLAP/IGFBP2/KRT19/TGFBR2,4
GO:0061448,GO:0061448,connective tissue development,8/191,260/18800,0.0052001560525917,0.0426483380897534,0.0295026119546314,ACTA2/ACVRL1/CCN4/MDK/NOTCH1/PKD1/TGFBR2/WNT9A,8
GO:0031293,GO:0031293,membrane protein intracellular domain proteolysis,2/191,11/18800,0.00531685619104,0.0426483380897534,0.0295026119546314,ADAM9/MMP7,2
GO:0010614,GO:0010614,negative regulation of cardiac muscle hypertrophy,3/191,35/18800,0.0053196189566683,0.0426483380897534,0.0295026119546314,NOTCH1/TNFRSF1A/TNFRSF1B,3
GO:0002456,GO:0002456,T cell mediated immunity,5/191,112/18800,0.0057377622352064,0.0453245313589107,0.0313539078098037,B2M/HLA-E/IL1R1/NECTIN2/TNFRSF1B,5
GO:0045742,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,3/191,36/18800,0.0057603528260664,0.0453245313589107,0.0313539078098037,AGR2/AREG/PLAUR,3
GO:0002526,GO:0002526,acute inflammatory response,5/191,113/18800,0.0059550401441885,0.0466409695890811,0.0322645732192089,B4GALT1/HLA-E/REG3A/TNFRSF11A/VCAM1,5
GO:0002832,GO:0002832,negative regulation of response to biotic stimulus,5/191,113/18800,0.0059550401441885,0.0466409695890811,0.0322645732192089,GRN/HAVCR2/HLA-E/MMP12/VSIG4,5
GO:0042246,GO:0042246,tissue regeneration,4/191,72/18800,0.0062039415597787,0.0481806841705806,0.0333296933118903,ERBB4/MDK/NOTCH1/TGFBR2,4
GO:0045916,GO:0045916,negative regulation of complement activation,2/191,12/18800,0.0063377731068556,0.0484143340247921,0.0334913240175828,CD59/VSIG4,2
GO:0071285,GO:0071285,cellular response to lithium ion,2/191,12/18800,0.0063377731068556,0.0484143340247921,0.0334913240175828,CDH1/FABP4,2
GO:0098911,GO:0098911,regulation of ventricular cardiac muscle cell action potential,2/191,12/18800,0.0063377731068556,0.0484143340247921,0.0334913240175828,DSC2/DSG2,2
